Cargando…
Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative Colitis
BACKGROUND AND AIMS: The calcineurin inhibitor tacrolimus is reportedly effective for moderate/severe ulcerative colitis (UC); however, it is also reportedly associated with nephrotoxicity. We investigated the risk factors for tacrolimus-induced nephrotoxicity and whether renal impairment adversely...
Autores principales: | Nakata, Satoshi, Kakimoto, Kazuki, Numa, Keijiro, Kinoshita, Naohiko, Kawasaki, Yuka, Tatsumi, Yoshihiro, Tawa, Hideki, Koshiba, Ryoji, Hirata, Yuki, Ota, Kazuhiro, Sakiyama, Naokuni, Kojima, Yuichi, Nishikawa, Hiroki, Inoue, Takuya, Takeuchi, Toshihisa, Fukunishi, Shinya, Miyazaki, Takako, Nakamura, Shiro, Higuchi, Kazuhide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932845/ https://www.ncbi.nlm.nih.gov/pubmed/35705006 http://dx.doi.org/10.1159/000524594 |
Ejemplares similares
-
Therapeutic Drug Monitoring of Golimumab for the Prediction of Long-Term Clinical Remission in Patients with Ulcerative Colitis
por: Tawa, Hideki, et al.
Publicado: (2022) -
Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis
por: Kinoshita, Naohiko, et al.
Publicado: (2022) -
Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis
por: Numa, Keijiro, et al.
Publicado: (2023) -
Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition
por: Kawasaki, Yuka, et al.
Publicado: (2023) -
Fr581 EVALUATION OF SEQUENTIAL CHANGES IN THE INTESTINAL FLORA OF PATIENTS TAKING LOW-DOSE ASPIRIN AND A PROTON-PUMP INHIBITOR
por: Hirata, Yuki, et al.
Publicado: (2021)